Company / Current Liabilities
Catalyst Pharmaceuticals Partners, Inc. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$147.2M
FY2025
5-year range
$27.1M / $147.2M
FY2021-FY2025
Trend
+21.9%
vs FY2024
Sector context
#73 of 213
Health Care
What the data says
At $147M, Catalyst Pharmaceuticals Partners, Inc.'s current liabilities ranks #141 of 213 in the Health Care sector. Current Liabilities has increased for 5 consecutive years, from $23M in FY2020 to $147M in FY2025.
Based on SEC 10-K filings.
$147M in FY2025 with a 5-year CAGR of +45.3%.
Increased from $76M to $147M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +36.7%
- 5-Year CAGR
- +45.3%
- 10-Year CAGR
- -
Sector benchmark
#141 of 213 in Health CareTop 66% of 213This company $147.2M Sector average $1.6B
▼
-90.7% below sector average
Key checks
Key Insights
- Catalyst Pharmaceuticals Partners, Inc.'s current liabilities has grown for 5 consecutive years.
- 5-year CAGR of +45.3%, indicating consistent growth.
- In FY2025, current liabilities increased 21.9% year-over-year.
- Ranks #73 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $147.2M | +21.9% |
| FY2024 | $120.7M | +58.7% |
| FY2023 | $76.1M | +32.1% |
| FY2022 | $57.6M | +112.8% |
| FY2021 | $27.1M | +18.9% |
| FY2020 | $22.8M | -5.6% |
| FY2019 | $24.1M | +153.4% |
| FY2018 | $9.5M | +122.9% |
| FY2017 | $4.3M | +103.7% |
| FY2016 | $2.1M | -39.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026